Difference between revisions of "ERCC1"
| Line 1: | Line 1: | ||
==Annotation== | ==Annotation== | ||
===Name=== | ===Name=== | ||
| − | + | ERCC1 | |
| − | |||
===Alias=== | ===Alias=== | ||
| Line 20: | Line 19: | ||
Biological Process: pathogenic process | Biological Process: pathogenic process | ||
| − | Description: | + | Description: NA |
Latest revision as of 02:22, 5 November 2018
Contents
Annotation
Name
ERCC1
Alias
NA
Disease
Disease: gastric cancer (PMID:25260808)
Dysfunction type: expression
Description: The expression level of AC138128.1 in GC was significantly decreased compared to that in NAT. Levels of AC138128.1 in the GC cell lines, AGS BGC-823, HG27, and SGC-7901 were lower than those in the human normal gastric epithelial cell line GES-1. lncRNA AC138128.1 might be a novel biomarker for predicting GC.
Function
Function Mechanism: NA (PMID:25260808)
Biological Process: pathogenic process
Description: NA
